-
Breaking information key to preclinical & clinical
development.
DailyUpdates'
panel of industry experts selects key information as it
appears in the scientific literature or in press releases.
Especial importance is placed on research & news items
describing
novel molecular targets;
proof of concept
data supporting emerging therapeutic areas;
clinical activity of developmental drugs
and;
regulatory affairs
-
Drug development news: Breaking news is selected
from the major press release services such as PRWire
& Business Wire. Drug development, clinical trial, and
regulatory affairs releases are all listed and linked through
to the full press release.
-
Cutting edge journal articles:
Proprietary search technology is used to scan PubMed on a
regular basis. Our panel of industry experts then selects from
this short-list articles judged to be of especial importance
to drug development. All content is linked to publishers
abstracts; depending on institutional licenses readers can
also access full text articles.
-
Editorial Comment: Our editors provide
information ranging from scientific background for more basic
research content to mechanism of action, drug development news
and market size for content relating to developmental
candidates.
-
Choice of therapeutic focus:
DailyUpdates
is focused on drug development. All information is packaged up into 14 therapeutic channels combining ease of use with comprehensive and focused tracking of the drug development sector.
online Trial: Please select one of the Therapeutic Channels below to view today's DailyUpdates online:
-
Electronic delivery & convenient search facility: DailyUpdates
is delivered by e-mail each working day. If you miss a
delivery or if you simply need to look for past inclusions, a
simple to use search facility is provided
-
Platinum option for individuals with a broad base of
interests: Although most users benefit from one or
more channels of
DailyUpdates
focusing on their areas of interest, some users have a broad
area of interest. Our Platinum pack is ideal for such
individuals. The Platinum pack offers access to content and
editorial comment across the range of
DailyUpdates
channels (note
that our search facility is not included in this option)
-
Low cost subscription: We have been able to keep
annual subscription costs down to £50/$90 in order to meet
most budgets...a small price to pay for the range of benefits
offered through
DailyUpdates.
Corporate subscription are available on request for
£300/channel entitling unlimited use of
DailyUpdates
within an entire organization
All information is packaged up into 14 therapeutic channels combining ease of use with comprehensive and focused tracking of the drug development sector.
Online Trial: Please select one of the
Therapeutic Channels below to view a sample of DailyUpdates online - to
request a FREE
trial please email
peter.barfoot@bioportfolio.com:
In addition LeadDiscobvery have launched DailyUpdatesPlus -
view free sample
Are you looking for rapid analysis of breaking R&D
activity that will impact on your drug development or marketing
activity? If you are UpdatesPlus is for you.
In depth
analysis of breaking research: LeadDiscovery already
delivers DailyUpdates one of the most popular alert services in
the pharmabiotech sector. Based on this proven track record of
identifying key R&D activity our industrial panel now offers,
through UpdatesPlus, analysis of its importance.
Delivered monthly in an easy to read
presentation-ready format: UpdatesPlus has been
designed to deliver analysis with clarity characteristic of
LeadDiscovery products. Delivered monthly in PowerPoint format,
UpdatesPlus is designed to be succinct, easy to read, and simple
to convert for the purposes of monthly internal meetings.
Want to find out more? View our free example by clicking the
link below
Does this work support a new
molecular target? Are we looking at a potential licensing
opportunity? Are our competitors advancing their pipeline or has
their lead just crashed? These are just some of the questions
answered in UpdatesPlus
Information sources: UpdatesPlus focuses on
material featured over the previous 4 weeks in DailyUpdates as
well as in additional sources. Sources include: Journal
articles; Press releases; Clinical Trial databases; Company
websites; Proprietary R&D databases; Investor presentations; Key
scientific conferences.
Focus: UpdatesPlus is client led. If you
have an area that needs to be tracked let us know. UpdatesPlus
is suited to covering multiple indications for a single
molecular target or multiple molecular targets for a single
indication
Cost & Delivery: UpdatesPlus is priced to
reflect the size of the area covered. The service can be priced
on an exclusive (just your company) or non-exclusive basis. In
either case UpdatesPlus is available on a company wide license.
Some companies prefer exclusivity since information provided by
UpdatesPlus sometimes has the potential to generate a
competitive advantage. By way of a guide, UpdatesPlus-Neuronal
Nicotinics is priced at $9,500/year. For this, 12 editions will
be produced.
